US Stock MarketDetailed Quotes

MLTX MoonLake Immunotherapeutics

Watchlist
  • 41.460
  • +1.280+3.19%
Trading Apr 30 11:09 ET
2.62BMarket Cap-21.94P/E (TTM)

About MoonLake Immunotherapeutics Company

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

Company Profile

SymbolMLTX
Company NameMoonLake Immunotherapeutics
Listing DateOct 20, 2020
CEODr. Jorge Santos da Silva
MarketNASDAQ
Employees100
Fiscal Year Ends12-31
AddressDorfstrasse 29
CityZug
ProvinceZug
CountrySwitzerland
Zip Code6300
Phone41-41-510-80-22

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jorge Santos da Silva
  • Chief Executive Officer and Director
  • 1.41M
  • Matthias Bodenstedt
  • Chief Financial Officer and Principal Accounting Officer
  • 1.03M
  • Dr. Kristian Reich
  • Chief Scientific Officer
  • 1.30M
  • Simon John Sturge
  • Chairman of the Board
  • 315.51K
  • Catherine Moukheibir
  • Independent Director
  • 287.51K
  • Spike Loy
  • Independent Director
  • 277.51K
  • Dr. Ramnik Xavier
  • Independent Director
  • 300.01K
  • Dr. Andrew Phillips, PhD
  • Independent Director
  • 281.01K

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More